Subphenotype-dependent disease markers for diagnosis and personalized treatment of autism spectrum disorders

Disease Markers

Volumn 33, Issue 5, 2012, Pages 277-288

  Hu, Valerie W ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Autism; clinical phenotypes; epigenetics; gene expression; gene environment interactions; genetics; genomics

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR ALPHA; UNTRANSLATED RNA;

AUTISM; DISEASE MARKER; DISEASE SEVERITY; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872359531     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2012/835728     Document Type: Review

References (90)

1. American Psychological Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychological Association, Washington, DC, 1994.
2. Centers for Disease Control and Prevention, Prevalence of autism spectrum disorders-Autism and developmental disabilities monitoring network, 14 sites, United States, 2008, MMWR Surveillance Summaries 61(ss03) (2012), 1-19.
3. A. Benvenuto, B. Manzi, R. Alessandrelli, C. Galasso and P. Curatolo, Recent advances in the pathogenesis of syndromic autisms, International Journal of Pediatrics 2009 (2009).
4. J.P. Gregg, L. Lit, C.A. Baron, I. Hertz-Picciotto, W. Walker, R.A. Davis, L.A. Croen, S. Ozonoff, R. Hansen, I.N. Pessah and F.R. Sharp, Gene expression changes in children with autism, Genomics 91 (2008), 22-29.
5. Y. Bradford, J. Haines, H. Hutcheson, M. Gardiner, T. Braun, V. Sheffield, T. Cassavant, W. Huang, K.Wang, V. Vieland, S. Folstein, S. Santangelo and J. Piven, Incorporating language phenotypes strengthens evidence of linkage to autism, American Journal of Medical Genetics-Neuropsychiatric Genetics 105 (2001), 539-547.
6. S.J. Spence, R.M. Cantor, L. Chung, S. Kim, D.H. Geschwind and M. Alarcon, Stratification based on language-related endophenotypes in autism: attempt to replicate reported linkage, Am J Med Genet B Neuropsychiatr Genet 141 (2006), 591-8.
7. J. Piven, The broad autismphenotype: Acomplementary strategy for molecular genetic studies of autism, American Journal of Medical Genetics 105 (2001), 34-35.
8. A. Bailey and J. Parr, Implications of the broader phenotype for concepts of autism, Novartis Found Symp 251 (2003), 26-35; discussion 36-47, 109-11, 281-97.
9. I.I. Gottesman and T.D. Gould, The endophenotype concept in psychiatry: Etymology and strategic intentions, American Journal of Psychiatry 160 (2003), 636-645.
10. M. Alarcon, A.L. Yonan, T.C. Gilliam, R.M. Cantor and D.H. Geschwind, Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs, Mol Psychiatry 10 (2005), 747-57.
11. G.K. Chen, N.Kono, D.H. Geschwind and R.M. Cantor, Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder, Mol Psychiatry 11 (2006), 214-20.
12. J.A. Duvall, A. Lu, R.M. Cantor, R.D. Todd, J.N. Constantino and D.H. Geschwind, A quantitative trait locus analysis of social responsiveness in multiplex autism families, Am J Psychiatry 164 (2007), 656-62.
13. H. Coon, M. Villalobos, R. Robison, N. Camp, D. Cannon, K. Allen-Brady, J. Miller and W. McMahon, Genome-wide linkage using the social responsiveness Scale in Utah autism pedigrees, Molecular Autism 1 (2010).
14. D. Cannon, J. Miller, R. Robison, M. Villalobos, N. Wahmhoff, K. Allen-Brady, W. McMahon and H. Coon, Genomewide linkage analyses of two repetitive behavior phenotypes in Utah pedigrees with autism spectrum disorders, Molecular Autism 1 (2010).
15. C. Lord, M. Rutter and A.L. Couteur, Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders, Journal of Autism and Developmental Disorders 24 (1994), 659-685.
16. V.W. Hu and M.E. Steinberg, Novel clustering of items from theAutismDiagnostic Interview-Revised to define phenotypes within autism spectrum disorders, Autism research: Official Journal of the International Society for Autism Research 2 (2009), 67-77.
17. V.W. Hu, T. Sarachana, K.S. Kim, A. Nguyen, S. Kulkarni, M.E. Steinberg, T. Luu, Y. Lai and N.H. Lee, Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism, Autismresearch: Official Journal of the International Society for Autism Research 2 (2009), 78-97.
18. T. Bourgeron, The possible interplay of synaptic and clock genes in autism spectrum disorders, Cold Spring Harbor symposia on quantitative biology 72 (2007), 645-654.
19. A.B.P. Van Kuilenburg, P. Vreken, N.G.G.M. Abeling, H.D. Bakker, R. Meinsma, H. Van Lenthe, R.A. De Abreu, J.A.M. Smeitink, H. Kayserili, M.Y. Apak, E. Christensen, I. Holopainen, K. Pulkki, D. Riva, G. Botteon, E. Holme, M. Tulinius, W.J. Kleijer, F.A. Beemer, M. Duran, K.E. Niezen-Koning, G.P.A. Smit, C. Jakobs, L.M.E. Smit, U. Moog, L.J.M. Spaapen and A.H. Van Gennip, Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency, Human Genetics 104 (1999), 1-9.
20. C.M. Freitag,W. Staal, S.M.Klauck, E.Duketis andR.Waltes, Genetics of autistic disorders: Review and clinical implications, European Child and Adolescent Psychiatry 19 (2010), 169-178.
21. A.R. Gupta and M.W. State, Recent advances in the genetics of autism, Biol Psychiatry 61 (2007), 429-37.
22. R. Muhle, S.V. Trentacoste and I. Rapin, The genetics of autism, Pediatrics 113 (2004), e472-86.
23. F. Polleux and J.M. Lauder, Toward a developmental neurobiology of autism, Ment Retard Dev Disabil Res Rev 10 (2004), 303-17.
24. S.L. Santangelo and K. Tsatsanis, What is known about autism: Genes, brain, and behavior, Am J Pharmacogenomics 5 (2005), 71-92.
25. M. Bucan, B.S. Abrahams, K. Wang, J.T. Glessner, E.I. Herman, L.I. Sonnenblick, A.I. Alvarez Retuerto, M. Imielinski, D. Hadley, J.P. Bradfield, C. Kim, N.B. Gidaya, I. Lindquist, T. Hutman, M. Sigman, V. Kustanovich, C.M. Lajonchere, A. Singleton, J. Kim, T.H. Wassink, W.M. McMahon, T. Owley, J.A. Sweeney, H. Coon, J.I. Nurnberger Jr., M. Li, R.M. Cantor, N.J. Minshew, J.S. Sutcliffe, E.H. Cook, G. Dawson, J.D. Buxbaum, S.F.A. Grant, G.D. Schellenberg, D.H. Geschwind and H. Hakonarson, Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes, PLoS Genetics 5 (2009).
26. J.T. Glessner, K. Wang, G. Cai, O. Korvatska, C.E. Kim, S. Wood, H. Zhang, A. Estes, C.W. Brune, J.P. Bradfield, M. Imielinski, E.C. Frackelton, J. Reichert, E.L. Crawford, J. Munson, P.M.A. Sleiman, R. Chiavacci, K. Annaiah, K. Thomas, C. Hou, W. Glaberson, J. Flory, F. Otieno, M. Garris, L. Soorya, L. Klei, J. Piven, K.J. Meyer, E. Anagnostou, T. Sakurai, R.M. Game, D.S. Rudd, D. Zurawiecki, C.J. Mc-Dougle, L.K. Davis, J. Miller, D.J. Posey, S. Michaels, A. Kolevzon, J.M. Silverman, R. Bernier, S.E. Levy, R.T. Schultz, G. Dawson, T. Owley, W.M. McMahon, T.H. Wassink, J.A. Sweeney, J.I. Nurnberger, H. Coon, J.S. Sutcliffe, N.J. Minshew, S.F.A. Grant, M. Bucan, E.H. Cook, J.D. Buxbaum, B. Devlin, G.D. Schellenberg and H. Hakonarson, Autism genome-wide copy number variation reveals ubiquitin and neuronal genes, Nature 459 (2009), 569-572.
27. J. Sebat, B. Lakshmi, D. Malhotra, J. Troge, C. Lese-Martin, T. Walsh, B. Yamrom, S. Yoon, A. Krasnitz, J. Kendall, A. Leotta, D. Pai, R. Zhang, Y.H. Lee, J. Hicks, S.J. Spence, A.T. Lee, K. Puura, T. Lehtimaki, D. Ledbetter, P.K. Gregersen, J. Bregman, J.S. Sutcliffe, V. Jobanputra, W. Chung, D.Warburton, M.C. King, D. Skuse, D.H. Geschwind, T.C. Gilliam, K. Ye and M.Wigler, Strong association of de novo copy number mutations with autism, Science 316 (2007), 445-9.
28. L.A. Weiss, D.E. Arking, M.J. Daly, A. Chakravarti, C.W. Brune, K. West, A. O'Connor, G. Hilton, R.L. Tomlinson, A.B. West, E.H. Cook Jr., T. Green, S. Chang, S. Gabriel, C. Gates, E.M. Hanson, A. Kirby, J. Korn, F. Kuruvilla, S. McCarroll, E.M. Morrow, B. Neale, S. Purcell, R. Sasanfar, C. Sougnez, C. Stevens, D. Altshuler, J. Gusella, S.L. Santangelo, P. Sklar, R. Tanzi, R. Anney, A.J. Bailey, G. Baird, A. Battaglia, T. Berney, C. Betancur, S. B̈olte, P.F. Bolton, J. Brian, S.E. Bryson, J.D. Buxbaum, I. Cabrito, G. Cai, R.M. Cantor, H. Coon, J. Conroy, C. Correia, C. Corsello, E.L. Crawford, M.L. Cuccaro, G. Dawson, M. De Jonge, B. Devlin, E. Duketis, S. Ennis, A. Estes, P. Farrar, E. Fombonne, C.M. Freitag, L. Gallagher, D.H. Geschwind, J. Gilbert, M. Gill, C. Gillberg, J. Goldberg, A. Green, J. Green, S.J. Guter, J.L. Haines, J.F. Hallmayer, V. Hus, S.M. Klauck, O. Korvatska, J.A. Lamb, M. Laskawiec, M. Leboyer, A. Le Couteur, B.L. Leventha, X.-. Liu, C. Lord, L.J. Lotspeich, E. Maestrini, T. Magalhaes, W. Mahoney, C. Mantoulan, H. McConachie, C.J. McDougle, W.M. McMahon, C.R. Marshall, J. Miller, N.J. Minshew, A.P. Monaco, J. Munson, J.I. Nurnberger Jr., G. Oliveira, A. Pagnamenta, K. Papanikolaou, J.R. Parr, A.D. Paterson, M.A. Pericak-Vance, A. Pickles, D. Pinto, J. Piven, D.J. Posey, A. Poustka, F. Poustka, R. Regan, J. Reichert, K. Renshaw, W. Roberts, B. Roge, M.L. Rutter, J. Salt, G.D. Schellenberg, S.W. Scherer, V. Sheffield, J.S. Sutcliffe, P. Szatmari, K. Tansey, A.P. Thompson, J. Tsiantis, H. Van Engeland, A.M. Vicente, V.J. Vieland, F. Volkmar, S.Wallace, T.H. Wassink, E.M. Wijsman, K. Wing, K. Wittemeyer, B.L. Yaspan, L. Zwaigenbaum, S.-. Yoo, R.S. Hill, N.M. Mukaddes, S. Balkhy, G. Gascon, S. Al-Saad, A. Hashmi, J. Ware, R.M. Joseph, E. LeClair, J.N. Partlow, B. Barry, C.A. Walsh, D. Pauls, I. Moilanen, H. Ebeling, M.-. Mattila, S. Kuusikko, K. Jussila, J. Ignatius, A. Tolouei, M. Ghadami, M. Rostami, A. Hosseinipour, M. Valujerdi, K. Andresen, B. Winkloski, S. Haddad, L. Kunkel, Z. Kohane, T. Tran, S. Won Kong, S.B. O'Neil, R. Hundley, I. Holm, H. Peters, E. Baroni, A. Cangialose, L. Jackson, L. Albers, R. Becker, C. Bridgemohan, S. Friedman, K. Munir, R. Nazir, J. Palfrey, A. Schonwald, E. Simmons, L.A. Rappaport, J. Gauthier, L.Mottron, R. Joober, G. Rouleau, K. Rehnstrom, L. Von Wendt and L. Peltonen, A genome-wide linkage and association scan reveals novel loci for autism, Nature 461 (2009), 802-808.
29. P. Szatmari, A.D. Paterson, L. Zwaigenbaum, W. Roberts, J. Brian, X.Q. Liu, J.B. Vincent, J.L. Skaug, A.P. Thompson, L. Senman, L. Feuk, C. Qian, S.E. Bryson, M.B. Jones, C.R. Marshall, S.W. Scherer, V.J. Vieland, C. Bartlett, L.V. Mangin, R. Goedken, A. Segre, M.A. Pericak-Vance, M.L. Cuccaro, J.R. Gilbert, H.H. Wright, R.K. Abramson, C. Betancur, T. Bourgeron, C. Gillberg, M. Leboyer, J.D. Buxbaum, K.L. Davis, E. Hollander, J.M. Silverman, J. Hallmayer, L. Lotspeich, J.S. Sutcliffe, J.L. Haines, S.E. Folstein, J. Piven, T.H.Wassink, V. Sheffield, D.H. Geschwind, M. Bucan, W.T. Brown, R.M. Cantor, J.N. Constantino, T.C. Gilliam, M. Herbert, C. Lajonchere, D.H. Ledbetter, C. Lese-Martin, J.Miller, S. Nelson, C.A. Samango-Sprouse, S. Spence, M. State, R.E. Tanzi, H. Coon, G. Dawson, B. Devlin, A. Estes, P. Flodman, L. Klei, W.M. McMahon, N. Minshew, J. Munson, E. Korvatska, P.M. Rodier, G.D. Schellenberg, M. Smith, M.A. Spence, C. Stodgell, P.G. Tepper, E.M. Wijsman, C.E. Yu, B. Roge, C. Mantoulan, K. Wittemeyer, A. Poustka, B. Felder, S.M. Klauck, C. Schuster, F. Poustka, S. Bolte, S. Feineis-Matthews, E. Herbrecht, G. Schmotzer, J. Tsiantis, K. Papanikolaou, E. Maestrini, E. Bacchelli, F. Blasi, S. Carone, C. Toma, H. Van Engeland, M. de Jonge, C. Kemner, F. Koop, M. Langemeijer, C. Hijimans, W.G. Staal, G. Baird, P.F. Bolton, M.L. Rutter, E.Weisblatt, J. Green, C. Aldred, J.A.Wilkinson, A. Pickles, A. Le Couteur, T. Berney, H. McConachie, A.J. Bailey, K. Francis, G. Honeyman, A. Hutchinson, J.R. Parr, S. Wallace, A.P. Monaco, G. Barnby, K. Kobayashi, J.A. Lamb, I. Sousa, N. Sykes, E.H. Cook, S.J. Guter, B.L. Leventhal, J. Salt, C. Lord, C. Corsello, V. Hus, D.E. Weeks, F. Volkmar, M. Tauber, E. Fombonne and A. Shih, Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Nat Genet 39 (2007), 319-28.
30. K. Wang, H. Zhang, D. Ma, M. Bucan, J.T. Glessner, B.S. Abrahams, D. Salyakina, M. Imielinski, J.P. Bradfield, P.M.A. Sleiman, C.E. Kim, C. Hou, E. Frackelton, R. Chiavacci, N. Takahashi, T. Sakurai, E. Rappaport, C.M. Lajonchere, J. Munson, A. Estes, O. Korvatska, J. Piven, L.I. Sonnenblick, A.I. Alvarez Retuerto, E.I. Herman, H. Dong, T. Hutman, M. Sigman, S. Ozonoff, A. Klin, T. Owley, J.A. Sweeney, C.W. Brune, R.M. Cantor, R. Bernier, J.R. Gilbert, M.L. Cuccaro, W.M. McMahon, J. Miller, M.W. State, T.H. Wassink, H. Coon, S.E. Levy, R.T. Schultz, J.I. Nurnberger, J.L. Haines, J.S. Sutcliffe, E.H. Cook, N.J. Minshew, J.D. Buxbaum, G. Dawson, S.F.A. Grant, D.H. Geschwind, M.A. Pericak-Vance, G.D. Schellenberg and H. Hakonarson, Common genetic variants on 5p14.1 associate with autism spectrum disorders, Nature 459 (2009), 528-533.
31. M. Alarćon, B.S. Abrahams, J.L. Stone, J.A. Duvall, J.V. Perederiy, J.M. Bomar, J. Sebat, M.Wigler, C.L.Martin, D.H. Ledbetter, S.F. Nelson, R.M. Cantor and D.H. Geschwind, Linkage, Association, and Gene-Expression Analyses Identify CNTNAP2 as an Autism-Susceptibility Gene, American Journal of Human Genetics 82 (2008), 150-159.
32. B. Bakkaloglu, B.J. O'Roak, A. Louvi, A.R. Gupta, J.F. Abelson, T.M. Morgan, K. Chawarska, A. Klin, A.G. Ercan-Sencicek, A.A. Stillman, G. Tanriover, B.S. Abrahams, J.A. Duvall, E.M. Robbins, D.H. Geschwind, T. Biederer, M. Gunel, R.P. Lifton and M.W. State, Molecular Cytogenetic Analysis and Resequencing of Contactin Associated Protein-Like 2 in Autism Spectrum Disorders, American Journal of Human Genetics 82 (2008), 165-173.
33. D.E. Arking, D.J. Cutler, C.W. Brune, T.M. Teslovich, K. West, M. Ikeda, A. Rea, M. Guy, S. Lin, E.H. Cook Jr. and A. Chakravarti, A Common Genetic Variant in the Neurexin Superfamily Member CNTNAP2 Increases Familial Risk of Autism, American Journal of HumanGenetics 82 (2008), 160-164.
34. C.M. Freitag, The genetics of autistic disorders and its clinical relevance: a reviewof the literature, Mol Psychiatry 12 (2007), 2-22.
35. A.M. Persico and T. Bourgeron, Searching for ways out of the autism maze: genetic, epigenetic and environmental clues, Trends in Neurosciences 29 (2006), 349-358.
36. V.W. Hu, A. Addington and A. Hyman, Novel autism subtypedependent genetic variants are revealed by quantitative trait and subphenotype association analyses of Published GWAS Data, PLoS ONE 6 (2011).
37. A. Sikander, S.V. Rana and K.K. Prasad, Role of serotonin in gastrointestinal motility and irritable bowel syndrome, Clinica Chimica Acta 403 (2009), 47-55.
38. M.R. Herbert, J.P. Russo, S. Yang, J. Roohi, M. Blaxill, S.G. Kahler, L. Cremer and E. Hatchwell, Autism and environmental genomics, Neurotoxicology 27 (2006), 671-84.
39. T. Buie, D.B. Campbell, G.J. Fuchs III, G.T. Furuta, J. Levy, J. Van DeWater, A.H.Whitaker, D. Atkins, M.L. Bauman, A.L. Beaudet, E.G. Carr, M.D. Gershon, S.L. Hyman, P. Jirapinyo, H. Jyonouchi, K. Kooros, R. Kushak, P. Levitt, S.E. Levy, J.D. Lewis, K.F. Murray, M.R. Natowicz, A. Sabra, B.K. Wershil, S.C.Weston, L. Zeltzer and H. Winter, Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: A consensus report, Pediatrics 125 (2010), S1-S18.
40. M. Nishimura, Y. Kuboi, K. Muramoto, T. Kawano and T. Imai, Chemokines as novel therapeutic targets for inflammatory bowel disease, Annals of the New York Academy of Sciences 1173 (2009), 350-356.
41. Y. Tani, E. Fernell, Y. Watanabe, T. Kanai and B. Langstrom, Decrease in GR-5,6,7,8-tetrahydrobiopterin content in cerebrospinal fluid of autistic patients, Neuroscience letters 181 (1994), 169-172.
42. R.E. Frye, L.C.Huffman andG.R. Elliott, Tetrahydrobiopterin as a novel therapeutic intervention for autism, Neurotherapeutics 7 (2010), 241-249.
43. V.W. Hu, A systems approach towards an understanding, diagnosis and personalized treatment of autismspectrumdisorders, Pharmacogenomics 12 (2011), 1235-1238.
44. J.C. Chuang and P.A. Jones, Epigenetics and microRNAs, Pediatr Res 61 (2007), 24R-29R.
45. J. Hsieh and A.J. Eisch, Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: Unraveling the genome to understand the mind, Neurobiology of disease 39 (2010), 73-84.
46. J. Feng and G. Fan, The Role of DNA Methylation in the Central Nervous System and Neuropsychiatric Disorders, International Review of Neurobiology 89 (2009), 67-84.
47. S. Martino, I. Di Girolamo, A. Orlacchio, A. Datti and A. Orlacchio, MicroRNA implications across neurodevelopment and neuropathology, Journal of Biomedicine and Biotechnology 2009 (2009).
48. J. Mill, T. Tang, Z. Kaminsky, T. Khare, S. Yazdanpanah, L. Bouchard, P. Jia, A. Assadzadeh, J. Flanagan, A. Schumacher, S. Wang and A. Petronis, Epigenomic Profiling Reveals DNA-Methylation Changes Associated withMajor Psychosis, American Journal of Human Genetics 82 (2008), 696-711.
49. T. Kerin, A. Ramanathan, K. Rivas, N. Grepo, G.W. Coetzee and D.B. Campbell, A noncoding RNA antisense to moesin at 5p14.1 in autism, Science Translational Medicine 4 (2012), 1.
50. T.W. Nilsen, Mechanisms of microRNA-mediated gene regulation in animal cells, Trends in Genetics 23 (2007), 243-249.
51. S. Bicker and G. Schratt, microRNAs: Tiny regulators of synapse function in development and disease, Journal of Cellular and Molecular Medicine 12 (2008), 1466-1476.
52. R. Fiore, G. Siegel and G. Schratt, MicroRNA function in neuronal development, plasticity and disease, Biochimica et Biophysica Acta-Gene Regulatory Mechanisms 1779 (2008), 471-478.
53. M. Kapsimali, W.P. Kloosterman, E. de Bruijn, F. Rosa, R.H. Plasterk and S.W. Wilson, MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system, Genome Biol 8 (2007), R173.
54. K.S. Kosik, The neuronal microRNA system, Nat Rev Neurosci 7 (2006), 911-20.
55. K. Abu-Elneel, T. Liu, F.S. Gazzaniga, Y. Nishimura, D.P. Wall, D.H. Geschwind, K. Lao and K.S.Kosik, Heterogeneous dysregulation ofmicroRNAs across the autism spectrum, Neurogenetics 9 (2008), 153-161.
56. Z. Talebizadeh, M.G. Butler and M.F. Theodoro, Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism, Autism Research 1 (2008), 307.
57. T. Sarachana, R. Zhou, G. Chen, H.K. Manji and V.W. Hu, Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines, Genome medicine 2 (2010), 23.
58. L.F. Sempere, S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky and V. Ambros, Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation, Genome Biol 5 (2004), R13.
59. A.M. Krichevsky, K.S. King, C.P. Donahue, K. Khrapko and K.S. Kosik, A microRNA array reveals extensive regulation of microRNAs during brain development, RNA 9 (2003), 1274-1281.
60. Y. Liang, D. Ridzon, L. Wong and C. Chen, Characterization of microRNA expression profiles in normal human tissues, BMC Genomics 8 (2007).
61. A. Schaefer, D. O'Carroll, L.T. Chan, D. Hillman, M. Sugimori, R. Llinas and P. Greengard, Cerebellar neurodegeneration in the absence of microRNAs, Journal of Experimental Medicine 204 (2007), 1553-1558.
62. S. Jung, R. Park, S. Kim, Y. Jeon, D. Ham, M. Jung, S. Kim, Y. Lee, C. Park and H. Suh-Kim, Id proteins facilitate self-renewal and proliferation of neural stem cells, Stem Cells and Development 19 (2010), 831-841.
63. A. Jogi, P. Persson, A. Grvnfeld, S. Pahlman and H. Axelson, Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation, JBiol Chem 277 (2002), 9118-9126.
64. C. Draghetti, C. Salvat, F. Zanoguera, M. Curchod, C. Vignaud, H. Peixoto, A. Di Cara, D. Fischer, M. Dhanabal, G. Andreas, H. Abderrahim, C. Rommel and M. Camps, Functional whole-genome analysis identifies polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator αB-crystallin, Journal of Biological Chemistry 284 (2009), 32053-32065.
65. K. Lee, Y. Lee, A. Rozeboom, J.-. Lee, N. Udagawa, H.-. Hoe and D. Pak, Requirement for Plk2 in Orchestrated Ras and Rap Signaling, Homeostatic Structural Plasticity, and Memory, Neuron 69 (2011), 957-973.
66. M.M. Ghahramani Seno, P. Hu, F.G. Gwadry, D. Pinto, C.R. Marshall, G. Casallo and S.W. Scherer, Gene and miRNA expression profiles in autism spectrum disorders, Brain research 1380 (2011), 85-97.
67. E.M.Kroh, R.K. Parkin, P.S.Mitchell andM. Tewari, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods 50 (2010), 298-301.
68. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B.Martin and M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 10513-10518.
69. D. Grafodatskaya, B. Chung, P. Szatmari and R. Weksberg, Autism Spectrum Disorders and Epigenetics, Journal of the American Academy of Child and Adolescent Psychiatry (2010).
70. A. Nguyen, T.A. Rauch, G.P. Pfeifer and V.W. Hu, Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain, The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 24 (2010), 3036-3051.
71. V.W. Hu, B.C. Frank, S. Heine, N.H. Lee and J. Quackenbush, Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes, BMC Genomics 7 (2006), 118.
72. V.W. Hu, A. Nguyen, K.S. Kim, M.E. Steinberg, T. Sarachana, M.A. Scully, S.J. Soldin, T. Luu and N.H. Lee, Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis, PloS one 4 (2009), e5775.
73. S.H. Fatemi, J.M. Stary, A.R. Halt and G.R. Realmuto, Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum, J Autism Dev Disord 31 (2001), 529-35.
74. S.H. Fatemi and A.R. Halt, Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism, Synapse 42 (2001), 281-4.
75. D.A. Gold, P.M. Gent and B.A. Hamilton, RORα in genetic control of cerebellum development: 50 staggering years, Brain research 1140 (2007), 19-25.
76. H.P. Harding, G.B. Atkins, A.B. Jaffe, W.J. Seo and M.A. Lazar, Transcriptional activation and repression by RORα, an orphan nuclear receptor required for cerebellar development, Molecular Endocrinology 11 (1997), 1737-1746.
77. F. Boukhtouche, M.Doulazmi, F. Frederic, I. Dusart, B. Brugg and J. Mariani, RORα, a pivotal nuclear receptor for Purkinje neuron survival and differentiation: From development to ageing, Cerebellum 5 (2006), 97-104.
78. F. Boukhtouche, G. Vodjdani, C.I. Jarvis, J. Bakouche, B. Staels, J. Mallet, J. Mariani, Y. Lemaigre-Dubreuil and B. Brugg, Human retinoic acid receptor-related orphan receptor α1 overexpression protects neurones against oxidative stressinduced apoptosis, Journal of Neurochemistry 96 (2006), 1778-1789.
79. P. Delerive, D. Monteì, G. Dubois, F. Trottein, J. Fruchart-Najib, J. Mariani, J. Fruchart and B. Staels, The orphan nuclear receptor RORα is a negative regulator of the inflammatory response, EMBO reports 2 (2001), 42-48.
80. F. Sato, T. Kawamoto, K. Fujimoto, M. Noshiro, K.K. Honda, S. Honma, K. Honma and Y. Kato, Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation: Interaction with BMAL1, European Journal of Biochemistry 271 (2004), 4409-4419.
81. R. Lalonde and C. Strazielle, Discrimination learning in Rorasg and Grid2ho mutant mice, Neurobiology of learning and memory 90 (2008), 472-474.
82. G. Goodall and G. Gheusi, Abnormal patterns of maze patrolling in the mutant mouse staggerer, Behavioral and neural biology 47 (1987), 307-320.
83. R. Lalonde, M.I. Botez and D. Boivin, Object exploration in staggerer mutant mice, Physiology and Behavior 41 (1987), 115-117.
84. R. Lalonde, Exploration and spatial learning in staggerer mutant mice, Journal of neurogenetics 4 (1987), 285-292.
85. M. Doulazmi, F. Fŕed́eric, Y. Lemaigre-Dubreuil, N. Hadj-Sahraoui, N. Delhaye-Bouchaud and J. Mariani, Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora+/Rora(sg)) is gender-related, Journal of Comparative Neurology 411 (1999), 267-273.
86. T. Sarachana, M. Xu, R.-C.Wu and V.W. Hu, Sex hormones in autism: Androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism, PLoS ONE 6 (2011), e17116.
87. R.C. Knickmeyer and S. Baron-Cohen, Fetal testosterone and sex differences in typical social development and in autism, J Child Neurol 21 (2006), 825-45.
88. E. Ingudomnukul, S. Baron-Cohen, S. Wheelwright and R. Knickmeyer, Elevated rates of testosterone-related disorders in women with autism spectrum conditions, Horm Behav 51 (2007), 597-604.
89. B. Auyeung, S. Baron-Cohen, E. Ashwin, R. Knickmeyer, K. Taylor and G. Hackett, Fetal testosterone and autistic traits, British Journal of Psychology 100 (2009), 1-22.
90. L.R. Chura, M.V. Lombardo, E. Ashwin, B. Auyeung, B. Chakrabarti, E.T. Bullmore and S. Baron-Cohen, Organizational effects of fetal testosterone on human corpus callosum size and asymmetry, Psychoneuroendocrinology 35 (2010), 122-132.